Gene · 132
Papers2,830
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,830
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Therapeutic Potential of Mesenchymal Stem Cells in the Treatment of Epilepsy and Their Interaction with Antiseizure Medications. | Cells | 2022 | 36552892 | PubTator, text mining | PubMed |
| N6-Isopentenyladenosine Impairs Mitochondrial Metabolism through Inhibition of EGFR Translocation on Mitochondria in Glioblastoma Cells. | Cancers (Basel) | 2022 | 36551529 | PubTator, text mining | PubMed |
| Ribose Intake as Food Integrator: Is It a Really Convenient Practice? | Biomolecules | 2022 | 36551203 | PubTator, text mining | PubMed |
| A convenient catalytic method for preparation of new tetrahydropyrido[2,3-d]pyrimidines via a cooperative vinylogous anomeric based oxidation. | RSC Adv | 2022 | 36545580 | PubTator, text mining | PubMed |
| INSM1 Expression in Mesenchymal Tumors and Its Clinicopathological Significance. | Biomed Res Int | 2022 | 36531655 | PubTator, text mining | PubMed |
| Predicting In Vitro and In Vivo Anti-SARS-CoV-2 Activities of Antivirals by Intracellular Bioavailability and Biochemical Activity. | ACS Omega | 2022 | 36530252 | PubTator, text mining | PubMed |
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1-rearranged NSCLC. | Transl Lung Cancer Res | 2022 | 36519016 | PubTator, text mining | PubMed |
| Residue-Dependent Transition Temperatures and Denaturant Midpoints in the Folding of a Multidomain Protein. | J Phys Chem B | 2022 | 36512486 | PubTator, text mining | PubMed |
| Focus on Marine Animal Safety and Marine Bioresources in Response to the SARS-CoV-2 Crisis. | Int J Mol Sci | 2022 | 36499463 | PubTator, text mining | PubMed |
| B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis. | Int J Mol Sci | 2022 | 36499368 | PubTator, text mining | PubMed |
| Modulation of the Inflammatory Response in Polycystic Ovary Syndrome (PCOS)-Searching for Epigenetic Factors. | Int J Mol Sci | 2022 | 36498989 | PubTator, text mining | PubMed |
| Trop-2 as a Therapeutic Target in Breast Cancer. | Cancers (Basel) | 2022 | 36497418 | PubTator, text mining | PubMed |
| Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysis. | Microbiome | 2022 | 36482486 | PubTator, text mining | PubMed |
| Inorganic Polyphosphate: Coacervate Formation and Functional Significance in Nanomedical Applications. | Int J Nanomedicine | 2022 | 36474526 | PubTator, text mining | PubMed |
| Adenosine and Adenosine Receptors: Advances in Atrial Fibrillation. | Biomedicines | 2022 | 36428533 | PubTator, text mining | PubMed |
| Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3'-Deoxyadenosine, as a Potential Anticancer Agent. | J Med Chem | 2022 | 36417756 | PubTator, text mining | PubMed |
| Adenylate Kinase-Catalyzed Reactions of AMP in Pieces: Specificity for Catalysis at the Nucleoside Activator and Dianion Catalytic Sites. | Biochemistry | 2022 | 36413937 | PubTator, text mining | PubMed |
| Persistence and In Vivo Evolution of Vaginal Bacterial Strains over a Multiyear Time Period. | mSystems | 2022 | 36413016 | PubTator, text mining | PubMed |
| EBV persistence in gastric cancer cases conventionally classified as EBER-ISH negative. | Infect Agent Cancer | 2022 | 36397137 | PubTator, text mining | PubMed |
| Nucleotide and nucleoside-based drugs: past, present, and future. | Saudi J Biol Sci | 2022 | 36389209 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/132/papers?page=15